3. Ouster, Inc. (NASDAQ: OUST)
Machine Vision Creates an Indirect Healthcare Robotics Connection
Ouster, Inc. (NASDAQ: OUST) participates in the healthcare robotics theme through enabling technology, particularly following its February 2026 acquisition of Stereolabs. The combined platform includes digital lidar, cameras, computing, and perception software used to help machines understand their surroundings.
A documented healthcare application predates the acquisition. In a July 2021 case study, Stereolabs described its stereovision technology being used by City Robotics’ Robo-UV, an autonomous disinfection robot designed for environments including hospital rooms.
That establishes a historical medical automation application for technology now within the acquired business. It does not establish that healthcare is a material current revenue source or that the company’s sensors have been approved for clinical diagnosis or treatment.
The investment connection is therefore indirect. Autonomous hospital equipment needs reliable navigation and environmental awareness, creating potential demand for perception systems. Whether that opportunity becomes financially significant depends on customer adoption and the scale of healthcare deployments.
Revenue Growth Comes From a Broader Automation Business
Ouster, Inc. (NASDAQ: OUST) reported approximately $55 million in second-quarter 2026 revenue, up 56% year over year. Shipments exceeded 17,000 lidar and camera sensors, while gross margin reached 49%.
The business nevertheless recorded an approximately $18 million quarterly net loss. Its cash, restricted cash, and short-term investments totaled approximately $263 million at June 30.
Industrial and smart infrastructure customers helped drive product revenue growth. Consequently, the 56% increase should be described as consolidated business growth, not growth in medical robotics sales.
For investors examining healthcare technology stocks, the appeal lies in supplying components that could serve multiple automation platforms. That diversification reduces dependence on one hospital application, while also making healthcare a smaller and less clearly measurable part of the overall thesis.
Ranking Rationale
Ouster, Inc. (NASDAQ: OUST) retains No. 3 based on its broader commercial scale, revenue growth, and improving gross margins. This position reflects business execution across automation markets rather than the strength of its healthcare exposure alone. On a ranking based strictly on demonstrated hospital operations, its indirect connection would deserve less weight.
